TERT promoter mutations and melanoma survival: A comprehensive literature review and meta-analysis-Reference-Cited by-同舟云学术

TERT promoter mutations and melanoma survival: A comprehensive literature review and meta-analysis

Published:2021-04 Issue: Volume:160 Page:103288
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Gandini Sara,Zanna Ines,De Angelis Simone,Palli Domenico,Raimondi Sara,Ribero Simone,Masala Giovanna^ORCID,Suppa Mariano,Bellerba Federica^ORCID,Corso Federica^ORCID,Nezi Luigi,Nagore Eduardo,Caini Saverio^ORCID

Funder

Ministero della Salute

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference48 articles.

1. TERT promoter mutation subtypes and survival in stage I and II melanoma patients;Andrés-Lencina;Int. J. Cancer,2019

2. MAPK pathway and TERT promoter gene mutation pattern and its prognostic value in melanoma patients: a retrospective study of 2,793 cases;Bai;Clin. Cancer Res.,2017

3. Systematic analysis of telomere length and somatic alterations in 31 cancer types;Barthel;Nat. Genet.,2017

4. The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism;Batista;Int. J. Cancer,2016

5. Telomerase: an RNP enzyme synthesizes DNA;Blackburn;Cold Spring Harb. Perspect. Biol.,2011

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utility and Micro-Costing Framework for TERT Promoter Mutation Analysis in Melanocytic Lesions of Uncertain Malignant Potential: A Retrospective Study in Dutch Local Clinical Practice;Diagnostics;2024-08-01

2. Comprehensive insights on genetic alterations and immunotherapy prognosis in Chinese melanoma patients;Scientific Reports;2024-07-18

3. Novel MED15::ATF1 fusion in a pediatric melanoma with spitzoid features and aggressive presentation;Genes, Chromosomes and Cancer;2024-03

4. Assessment of complete lymph node dissection in patients with melanoma: A systemic review and meta-analysis;Chinese Journal of Plastic and Reconstructive Surgery;2023-12

5. Entrectinib for NTRK Fusion-Positive Metastatic Melanoma Progressing on Combined PD-1 and CTLA-4 Inhibition: A Case Report;Case Reports in Oncology;2023-11-24